CSL Joins Blood & Beyond Initiative

We are proud to announce we have received a positive CHMP opinion for our once-monthly treatment targeting factor Xlla to prevent hereditary angioedema attacks. Read more: https://bit.ly/3ZSGmeG.

Advancing good blood health across Europe and globally is of vital importance. Today, CSL and Bristol Myers Squibb announce their partnership to continue to support the multi-stakeholder #BloodandBeyond initiative. Involving experts from hematology, transfusion medicine, patient blood management (PBM), nursing, patient advocacy, health economics, and hospital management, the multi-stakeholder initiative will continue to raise awareness of the importance of good blood health and the negative impact of anemia, and will help improve patient outcomes, including by promoting the implementation of #PBM across Europe and globally. Read more here https://bit.ly/4gwpTSz and discover more about the initiative https://bit.ly/4gtEsX9

Did you know that hemophilia A affects about 1 in 12,000 people? It’s caused by a deficiency in clotting factor VIII, which is essential for proper blood clotting. Living with hemophilia A can present unique challenges. CSL is dedicated to supporting patients and families affected by this bleeding disorder. #HemophiliaA Learn how you can support someone living with hemophilia A: https://bit.ly/4g500JZ

🌍 VIDEO: Shaping the Future, Together 🌍 Our inaugural R&D CAMP (CSL Academic Mentoring Program), co-organized by CSL and Life Science Zurich Young Scientist Network , provided valuable industry insights and career advice to life science students from diverse disciplines. At the same time, our internal mentors stepped up as leaders, refining their coaching skills and making a meaningful impact. This collaboration of minds and disciplines highlights the power of mentorship in creating a brighter future - together, we’ve built a foundation for innovation and growth! #DrivenbyOurPromise #Mentorship #FutureLeaders #LSZYSN

Outbreaks of avian influenza, infecting birds, livestock, and some humans continue to raise concerns of a potential pandemic. Health authorities maintain that the risk to the general public is low but continue to monitor the situation closely. Pandemics are a matter of “when,” not “if.” Effective pandemic preparedness and response requires a collaborative effort, and CSL Seqirus is a proud partner to over thirty governments worldwide, leveraging our state-of-the-art manufacturing facilities across three continents in both the northern and southern hemispheres. Examples of our strong partnerships with governments across the world include the recent announcement of a fifth and sixth BARDA award to further support the U.S. government’s pandemic preparedness efforts, as well as an award signed with HERA in the summer to help the European Commission’s pre-pandemic response. #CSLSeqirus #DrivenByOurPromise

At CSL, we are driven by our promise to save lives and improve patient well-being around the world. We're dedicated to developing innovative therapies for rare and serious diseases, expanding access to lifesaving medicines, and always prioritizing the safety and trust of our donors and stakeholders. #HealthierCommunities Learn more about our commitment to healthier communities: https://bit.ly/4f1iU3a

At CSL, helping to protect the public’s health is a top priority. According to the U.S. Centers for Disease Control and Prevention (CDC), getting a flu vaccine each year is the best way to help prevent potentially serious flu illness from spreading through your community. This U.S. National Influenza Vaccination Week, talk to your healthcare provider about the flu vaccine that’s right for you. Learn more about what we do: https://bit.ly/3BlaTYQ #CSLSeqirus #NIVW #influenza #CDC #DrivenByOurPromise #Flu #vaccination

CSL is thrilled to announce that our Australian Graduate Program has received the 2024 Will Spensley Memorial Award for Innovation at the AGRIAs, an event hosted by the Australian Association of Graduate Employers \(AAGE\). This award recognises our unwavering commitment to fostering innovative thinking and providing exceptional opportunities for our graduates. We extend a special thanks to our program’s partner, Fusion Graduate Consultancy, who help drive the success of our wonderful Graduate Program. At CSL, we’re committed to Promising Futures. If you are ready to make an impact and do of work that matters, join our award-winning Graduate Program today! https://bit.ly/3B1qmNR #earlycareers #promisingfutures #innovation #AAGE #AGRIAS #graduates #interns #doworkthatmatters #csl

Last month our three CSL sites in Switzerland buzzed with energy and enthusiasm as we celebrated Swiss National Future Day! Around 90 young people, ages 9 to 13, participated in a variety of engaging activities. From conducting experiments and exploring our facilities on guided tours, to soldering their own CSL logo-shaped hot wire creations, the enthusiasm and energy were truly contagious! These experiences gave the young visitors a firsthand look into the world of biopharmaceutical innovation and a chance to immerse themselves in CSL’s vibrant corporate culture. It was a fantastic opportunity for them to discover the exciting early career opportunities our organization offers. Learn more about other activities at CSL. https://bit.ly/3Vnl9Xz #promisingfutures #youngtalents #CSL #Switzerland

Watch a two-minute video to learn how chronic inflammatory demyelinating polyneuropathy \(CIDP\) affects the nerves and how a treatment called immunoglobulin therapy works on the immune system to help manage the condition. https://bit.ly/4g0UlVr